Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Le informazioni sui progetti di Orizzonte 2020 e ora anche le relative sintesi delle relazioni sono disponibili su CORDIS. Tutti i progetti H2020 possono essere scaricati dal Portale Open Data dell'UE .

My refinements


Download results of this page


Perfeziona per:

Tipo di contenuto

Progetto (1008)
Risultato in breve (5046)
Sintesi della relazione (1368)

Paese

Albania (7)
Algeria (2)
Argentina (11)
Armenia (2)
Australia (42)
Austria (412)
Bangladesh (5)
Belgio (658)
Benin (5)
Bielorussia (3)
Bolivia (3)
Bosnia-Erzegovina (3)
Botswana (2)
Brasile (20)
Bulgaria (23)
Burkina Faso (12)
Cambogia (2)
Camerun (7)
Canada (31)
Cile (3)
Cina (15)
Cipro (10)
Colombia (10)
Corea del Sud (5)
Costa Rica (1)
Croazia (29)
Cuba (2)
Danimarca (321)
Ecuador (3)
Egitto (7)
El Salvador (1)
Emirati arabi uniti (1)
Estonia (49)
Etiopia (5)
Ex Repubblica iugoslava di Macedonia (5)
Filippine (3)
Finlandia (253)
Francia (1269)
Gabon (3)
Gambia (1)
Georgia (4)
Germania (1854)
Ghana (16)
Giappone (8)
Giordania (1)
Grecia (191)
Guatemala (2)
Guinea-Bissau (1)
Haiti (1)
Hong Kong (3)
India (31)
Indonesia (7)
Iran (1)
Irlanda (320)
Islanda (35)
Isole Vergini britanniche (1)
Israele (150)
Italia (1017)
Kazakstan (3)
Kenya (13)
Lettonia (16)
Libano (1)
Lituania (23)
Lussemburgo (15)
Malawi (8)
Malaysia (3)
Mali (6)
Malta (4)
Marocco (6)
Maurizio (1)
Messico (7)
Moldova (5)
Mozambico (5)
Namibia (1)
Nepal (3)
Nicaragua (1)
Niger (7)
Nigeria (9)
Norvegia (163)
Nuova Zelanda (5)
Oman (1)
Paesi Bassi (1326)
Pakistan (2)
Palestina (2)
Papua Nuova Guinea (1)
Perú (5)
Polinesia francese (1)
Polonia (112)
Portogallo (76)
Regno Unito (1730)
Repubblica ceca (85)
Repubblica centrafricana (1)
Repubblica democratica del Congo (2)
Romania (47)
Russia (24)
Senegal (5)
Serbia (8)
Singapore (5)
Siria (2)
Slovacchia (16)
Slovenia (46)
Spagna (751)
Sri Lanka (2)
Stati Uniti (113)
Sud Africa (30)
Sudan (6)
Svezia (753)
Svizzera (485)
Taiwan (3)
Tanzania (18)
Thailandia (7)
Togo (1)
Tunisia (9)
Turchia (31)
Ucraina (8)
Uganda (16)
Ungheria (117)
Uruguay (4)
Uzbekistan (2)
Venezuela (2)
Vietnam (8)
Zambia (3)

Advanced search

Cerca progetti e risultati

Results 1 - 10 of 7422
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Final Report Summary - PAINCAGE (The NGF system and its interplay with endocannabinoid signalling, from peripheral sensory terminals to the brain: new targets for the development of next generation drugs for neuropathic pain)
Chronic pain (CP) is a pervasive yet unmet medical condition for which effective and safe drugs are badly needed. There is no effective treatment for this highly disabling disease state and current treatments (NSAIDs and opioids) cause serious side-effects. Eventually, surgery...
Programme: FP7-HEALTH
Record Number: 202997
Last updated on: 2017-09-12
The NGF system and its interplay with endocannabinoid signalling, from peripheral sensory terminals to the brain: new targets for the development of next generation drugs for neuropathic pain
ID: 603191
Data di inizio: 2014-04-01, Termine: 2017-12-31
So far, there are no effective treatments for neuropathic pain (NP), and current treatments suffer from serious unwanted side effects. The NGF ligand-receptor system has recently emerged as a novel target for NP of great therapeutic potential, a master regulator, controlling ...
Programme: FP7-HEALTH
Record Number: 185456
Last updated on: 2017-10-06
Nächste Generation von Medikamenten gegen neuropathischen Schmerz
Bei chronischen Schmerzen handelt es sich um einen medizinischen Zustand, der mit nicht-steroidalen Antirheumatika (NSAR) und Opioiden behandelt wird. Aufgrund der damit verbundenen Nebenwirkungen dieser Behandlungen sind allerdinge wirksame und sichere Medikamente dringend er...
Programme: FP7-HEALTH
Record Number: 211405
Last updated on: 2017-12-14
Available languages: DE, EN, ES, FR, IT, PL
Farmaci di ultimissima generazione per il dolore neuropatico
Il dolore cronico (CP) è una problematica medica attualmente trattata con farmaci antinfiammatori non steroidei (NSAID) e oppioidi. Gli effetti collaterali associati a tali trattamenti accentuano però l’esigenza di farmaci efficaci e sicuri.
Programme: FP7-HEALTH
Record Number: 211405
Last updated on: 2017-12-14
Available languages: DE, EN, ES, FR, IT, PL
Next generation drugs for neuropathic pain
Chronic pain (CP) is a medical condition currently treated with non-steroid anti-inflammatory drugs (NSAIDs) and opioids. However, the associated side-effects of these treatments emphasise the need for effective and safe drugs.
Programme: FP7-HEALTH
Record Number: 211405
Last updated on: 2017-12-14
Available languages: DE, EN, ES, FR, IT, PL
Una nueva generación de fármacos para el tratamiento del dolor neuropático
El dolor crónico (CP) es una afección clínica cuyo tratamiento actual consiste en la administración de fármacos antiinflamatorios no esteroideos (AINE) y opioides. Sin embargo, los efectos secundarios relacionados con uso de estos agentes terapéuticos ponen de manifiesto la ne...
Programme: FP7-HEALTH
Record Number: 211405
Last updated on: 2017-12-14
Available languages: DE, EN, ES, FR, IT, PL
Une nouvelle génération de médicament pour les douleurs neuropathiques
La douleur chronique (DC) est un état médical actuellement traité à base de médicaments anti-inflammatoires non stéroïdien (AINS) et d’opiacés. Mais les effets secondaires de ces médicaments exigent des alternatives efficaces et sûres à la fois.
Programme: FP7-HEALTH
Record Number: 211405
Last updated on: 2017-12-14
Available languages: DE, EN, ES, FR, IT, PL
Nowa generacja leków do leczenia bólu neuropatycznego
Przewlekły ból jest chorobą, której leczenie polega obecnie na stosowaniu niesteroidowych leków przeciwzapalnych i opioidów. Jednak powiązane skutki uboczne tych terapii podkreślają potrzebę opracowania skutecznych i bezpiecznych leków.
Programme: FP7-HEALTH
Record Number: 211405
Last updated on: 2017-12-14
Available languages: DE, EN, ES, FR, IT, PL
Periodic Report Summary 2 - OPTIMISTIC (Observational Prolonged Trial In Myotonic dystrophy type 1 to Improve QoL-Standards, a Target Identification Collaboration)
Myotonic dystrophy type1 (DM1) is a rare, inherited, chronic progressive disease as well as an autosomal dominant multisystemic disorder. It is the most common adult form of muscular dystrophy, with a prevalence of approximately 10 per 100,000...
Programme: FP7-HEALTH
Record Number: 182371
Last updated on: 2016-05-23
Observational Prolonged Trial In Myotonic dystrophy type 1 to Improve QoL-Standards, a Target Identification Collaboration
ID: 305697
Data di inizio: 2012-11-01, Termine: 2017-04-30
OPTIMISTIC is a proposal for a European collaborative project of doctors, scientists, relevant stakeholders (TREAT-NMD, patient organizations) and SMEs with the aim to improve clinical practice for patients suffering from a rare, inherited, and neglected disease, myotonic dys...
Programme: FP7-HEALTH
Record Number: 106243
Last updated on: 2017-12-07
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-12-15